PureTech Health plc
- PRTC
- NASDAQ
- Biotechnology
- Inflammatory/Oncology Pipeline
- Biotech R&D
$17.38
Today +2.12%Quote Jul 17, 2026, 01:30 PM UTC
+1.40%over the last month
Max drawdown −10.6%From 1-month high −6.6%3 months +0.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About PureTech Health
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
56
Market value
$41.9M
Approximate share count
Floor
$17.11
1.6% below price
Resistance
$18.02
3.7% above price
Price vs analyst targets
2 analysts
Lowest target
$44.00Highest target
$70.00
$44.00Highest target
$70.00
- Price $17.38
- Average target $57.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 228% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PRTCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free